Legal & General Group PLC Heron Therapeutics, Inc. Transaction History

Legal & General Group PLC

$368 Billion
Q4 2024

A detailed history of Legal & General Group PLC transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 10,432 shares of HRTX stock, worth $18,047. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,432

Previous 10,432 -0.0%

Holding current value

$18,047

Previous $20,000 25.0%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$2.32 - $3.86 $489 - $814	-211 Reduced 1.98%	10,432 $36,000
Q4 2023 Feb 15, 2024	SELL	$0.54 - $1.82 $642 - $2,165	-1,190 Reduced 10.06%	10,643 $18,000
Q2 2023 Aug 14, 2023	SELL	$1.11 - $2.88 $9,328 - $24,203	-8,404 Reduced 41.53%	11,833 $13,000
Q1 2023 May 15, 2023	SELL	$1.51 - $3.25 $36,403 - $78,351	-24,108 Reduced 54.36%	20,237 $30,000
Q4 2022 Feb 14, 2023	SELL	$2.25 - $4.67 $2,684 - $5,571	-1,193 Reduced 2.62%	44,345 $110,000
Q3 2022 Nov 14, 2022	SELL	$2.66 - $5.37 $76,631 - $154,704	-28,809 Reduced 38.75%	45,538 $192,000
Q2 2022 Aug 22, 2022	BUY	$2.3 - $6.29 $2,562 - $7,007	1,114 Added 1.52%	74,347 $208,000
Q1 2022 May 16, 2022	BUY	$4.63 - $9.94 $5,495 - $11,798	1,187 Added 1.65%	73,233 $418,000
Q4 2021 Feb 14, 2022	BUY	$8.35 - $12.6 $1,845 - $2,784	221 Added 0.31%	72,046 $658,000
Q3 2021 Nov 15, 2021	BUY	$10.13 - $15.0 $187,678 - $277,905	18,527 Added 34.76%	71,825 $768,000
Q1 2021 May 17, 2021	BUY	$14.49 - $20.72 $7,708 - $11,023	532 Added 1.01%	53,298 $864,000
Q4 2020 Feb 12, 2021	SELL	$14.61 - $22.14 $1,694 - $2,568	-116 Reduced 0.22%	52,766 $1.12 Million
Q3 2020 Nov 13, 2020	SELL	$13.67 - $17.77 $52,328 - $68,023	-3,828 Reduced 6.75%	52,882 $783,000
Q2 2020 Aug 14, 2020	BUY	$10.89 - $21.47 $148,398 - $292,571	13,627 Added 31.63%	56,710 $835,000
Q1 2020 May 14, 2020	SELL	$10.23 - $24.56 $37,871 - $90,921	-3,702 Reduced 7.91%	43,083 $505,000
Q4 2019 Feb 13, 2020	BUY	$17.42 - $26.61 $105,303 - $160,857	6,045 Added 14.84%	46,785 $1.1 Million
Q3 2019 Nov 13, 2019	BUY	$16.36 - $21.39 $189,056 - $247,182	11,556 Added 39.6%	40,740 $754,000
Q2 2019 Aug 14, 2019	BUY	$16.93 - $26.22 $22,550 - $34,925	1,332 Added 4.78%	29,184 $543,000
Q1 2019 May 15, 2019	BUY	$23.15 - $28.34 $6,667 - $8,161	288 Added 1.04%	27,852 $680,000
Q4 2018 Feb 15, 2019	BUY	$22.03 - $32.01 $36,988 - $53,744	1,679 Added 6.49%	27,564 $716,000
Q3 2018 Nov 20, 2018	BUY	$30.0 - $40.85 $467,970 - $637,219	15,599 Added 151.65%	25,885 $819,000
Q2 2018 Aug 10, 2018	BUY	$26.4 - $42.0 $6,045 - $9,618	229 Added 2.28%	10,286 $400,000
Q1 2018 May 17, 2018	SELL	$18.43 - $28.8 $24,235 - $37,872	-1,315 Reduced 11.56%	10,057 $277,000
Q4 2017 Feb 13, 2018	BUY	$14.8 - $18.85 $168,305 - $214,362	11,372	11,372 $208,000

Others Institutions Holding HRTX

# of Institutions

173

Shares Held

114M

Call Options Held

Put Options Held

32.4K

View Full List

About HERON THERAPEUTICS, INC.

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $205M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

More about HRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Heron Therapeutics, Inc. Transaction History